Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-14

Clinical Trial Update: A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome [NA]

View source ↗

Summary

This update notes the completion of a placebo-controlled, double-masked clinical trial evaluating an essential fatty acid supplement for Dry Eye Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Essential Fatty Acid Supplement (essential fatty acids)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Dry Eye Syndrome | NA | Status: COMPLETED